Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
BGI Genomics Sets Up Biotech Company in Tianjin
36Kr learned from Tianyancha App that Tianjin BGI Jibiai Biotechnology Co., Ltd. was recently established. The legal representative is Liu Shiliang, with registered capital of RMB 10 million and a registered address in the Tianjin Pilot Free Trade Zone. Its business scope includes production and sale of Class I medical devices, sale of Class II medical devices, sale of specialized chemical products, and import and export of goods. Shareholder information shows the company is wholly owned by Shenzhen BGI Genomics Co., Ltd.
Read the full article at 36KrRelated coverage
Europe SPAC Summit 2026 to Convene Leading SPAC Sponsors, Investors, and European Growth Companies in Zurich on December 10
parisguardian.com · Aug 19, 2026
Europe SPAC Summit 2026 to Convene Leading SPAC Sponsors, Investors, and European Growth Companies in Zurich on December 10
europesun.com · Aug 19, 2026
Europe SPAC Summit 2026 to Convene Leading SPAC Sponsors , Investors , and European Growth Companies in Zurich on December 10
manilatimes.net · Aug 4, 2026
2026 - 07 - 20 | Datavault AI ( DVLT ) Announces Q3 2026 Strategic Goals and Operational Objectives | NDAQ : DVLT
stockhouse.com · Jul 20, 2026